Table 3.
Comparison of peak FEV 1 for abediterol versus placebo and abediterol versus salbutamol
| Least–squares mean difference (standard error) | 95% confidence interval | |
|---|---|---|
| Abediterol 2.5 μg vs. placebo | 0.405 (0.027) | 0.353, 0.458 |
| Abediterol 1.25 μg vs. placebo | 0.371 (0.027) | 0.318, 0.424 |
| Abediterol 0.625 μg vs. placebo | 0.322 (0.027) | 0.269, 0.375 |
| Abediterol 0.313 μg vs. placebo | 0.274 (0.027) | 0.221, 0.327 |
| Salbutamol 400 μg vs. placebo | 0.353 (0.027) | 0.299, 0.406 |
| Abediterol 2.5 μg vs. salbutamol 400 μg | 0.0529 (0.0270) | -0.0002, 0.1061 |
| Abediterol 1.25 μg vs. salbutamol 400 μg | 0.0181 (0.0269) | -0.0350, 0.0711 |
| Abediterol 0.625 μg vs. salbutamol 400 μg | -0.0308 (0.0269) | -0.839, 0.0223 |
| Abediterol 0.313 μg vs. salbutamol 400 μg | -0.0783 (0.0269) | -0.1313, -0.0253 |
Data included for comparisons of all doses of abediterol with placebo and with salbutamol.